Genetic Modifiers of Lung Disease in Cystic Fibrosis
Top Cited Papers
- 6 October 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (14) , 1443-1453
- https://doi.org/10.1056/nejmoa051469
Abstract
Polymorphisms in genes other than the cystic fibrosis transmembrane conductance regulator (CFTR) gene may modify the severity of pulmonary disease in patients with cystic fibrosis.Keywords
This publication has 41 references indexed in Scilit:
- TGFβ signaling in health and diseaseNature Genetics, 2004
- Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosisPharmacogenetics, 2004
- Transforming growth factor- 1 genotype and susceptibility to chronic obstructive pulmonary diseaseThorax, 2004
- The International HapMap ProjectNature, 2003
- Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysemaNature, 2003
- Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairsHuman Genetics, 2003
- Disruption of the gene encoding the latent transforming growth factor-β binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancerGenes & Development, 2002
- TGFβ1 allele association with asthma severityHuman Genetics, 2001
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Detecting Marker-Disease Association by Testing for Hardy-Weinberg Disequilibrium at a Marker LocusAmerican Journal of Human Genetics, 1998